Cite

HARVARD Citation

    Bauditz, J. et al. (2002). Thalidomide reduces tumour necrosis factor α and interleukin 12 production in patients with chronic active Crohn's disease. Gut. 50 (2), pp. 196-200. [Online]. 
  
Back to record